AC Immune (ACIU) Q1 2026 Earnings
ACIU·Reported April 30, 2026·Before market open
AC Immune reported Q1 2026 revenue of $1.4M (+20.4% YoY), beat analyst consensus of $329.4K by $1.1M. Diluted EPS came in at $-0.19 (+9.5% YoY), beat the $-0.20 consensus by $0.01.
Revenue
$1.4Mbeat by $1.1M
Consensus: $329.4KDiluted EPS
$-0.19beat by $0.01
Consensus: $-0.20
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2026 Earnings FAQ
Common questions about AC Immune's Q1 2026 earnings report.
AC Immune (ACIU) reported Q1 2026 earnings on April 30, 2026 before market open.
AC Immune reported revenue of $1.4M and diluted EPS of $-0.19 for Q1 2026.
Revenue beat the consensus estimate of $329.4K by $1.1M. EPS beat the consensus estimate of $-0.20 by $0.01.
Compared to the same quarter a year prior, revenue grew 20.4% from $1.2M a year earlier and diluted EPS grew 9.5% from $-0.21.